It has only been recently with better antibody detection methods using cell based assays, which detect MOG in its native conformational state, that MOG-antibody has emerged as a biomarker for CNS inflammatory demyelinating disorders distinct from MS and NMOSD. Here, MOG is linked to myeloid sarcoma.